This site complies with the HONcode standard for trustworthy health information: verify here.
Oncology Clinical News
FDA Names Flatiron Health Executive Amy Abernethy Deputy Commissioner
(Forbes) Dec 17, 2018 - The Food and Drug Administration has named Amy Abernethy, currently the chief medical officer at Flatiron Health, a unit of the drug giant Roche, to one of its highest positions. She will start in a few months. Abernethy, an oncologist who is credited with helping Flatiron transform data collected from electronic medical records into information that might become acceptable to FDA regulators, will be the Principal Deputy Commissioner for Food and Drugs. This is the highest position at the FDA that is not a political appointment.
Read full article.
ASCO, ESMO Publish Joint Assessment of Their Value Frameworks
This site complies with the HONcode standard for trustworthy health information: verify here.